VBL Presents New Data on the Potential of its Novel VB-600 Platform for Nonalcoholic Steatohepatitis (NASH) and Rheumatoid Arthritis (RA)

February 26, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search